百傲化学(603360) - 2023 Q1 - 季度财报

Financial Performance - The company's operating revenue for Q1 2023 was ¥257,856,883.15, representing a decrease of 12.31% compared to the same period last year [3] - The net profit attributable to shareholders for Q1 2023 was ¥72,655,074.26, down 26.21% year-on-year [3] - The net profit attributable to shareholders after deducting non-recurring gains and losses was ¥71,804,390.36, a decline of 26.45% compared to the previous year [3] - Basic earnings per share for Q1 2023 were ¥0.29, down 25.64% from the same period last year [3] - The net profit for Q1 2023 was CNY 72,655,074.26, a decrease of 26.2% compared to CNY 98,465,601.61 in Q1 2022 [15] - Total revenue from operating activities was CNY 219,783,613.73, down 10.0% from CNY 244,334,279.59 in the same period last year [18] - The total profit before tax was CNY 83,488,195.88, down from CNY 117,134,708.98 in the previous year [15] - The company reported a total comprehensive income of CNY 71,180,490.46, down from CNY 98,464,327.84 in Q1 2022 [16] Cash Flow and Liquidity - The net cash flow from operating activities was ¥113,334,039.98, showing a slight decrease of 2.06% year-on-year [3] - Cash and cash equivalents increased to CNY 516,010,928.77 as of March 31, 2023, up from CNY 417,962,525.12 at the end of 2022, indicating improved liquidity [10] - The operating cash flow net amount was CNY 113,334,039.98, slightly down from CNY 115,713,254.47 in Q1 2022 [18] - The net cash flow from investing activities was -¥10,072,692.56, improving from -¥86,632,410.08 in Q1 2022 [26] - The net increase in cash and cash equivalents for Q1 2023 was ¥98,932,364.09, compared to a decrease of -¥36,487,878.77 in Q1 2022 [26] - The ending balance of cash and cash equivalents reached ¥494,115,594.51, significantly up from ¥173,767,264.53 in the previous year [26] Assets and Liabilities - The total assets at the end of the reporting period were ¥1,822,250,531.34, an increase of 3.87% compared to the end of the previous year [3] - Total assets as of March 31, 2023, were CNY 1,822,250,531.34, an increase from CNY 1,754,392,289.92 at the end of 2022 [12] - Total liabilities decreased to CNY 285,987,363.08 from CNY 293,121,208.91, reflecting a reduction in financial obligations [12] - Shareholders' equity increased to CNY 1,536,263,168.26 from CNY 1,461,271,081.01, indicating growth in the company's net worth [12] - Total assets increased to CNY 1,825,185,387.46 as of March 31, 2023, up from CNY 1,757,275,735.91 at the end of 2022, representing a growth of approximately 3.8% [21] - Current assets rose to CNY 1,128,781,988.25, compared to CNY 1,050,281,587.57, marking an increase of about 7.5% [20] Shareholder Information - The top two shareholders hold significant stakes, with 大连通运投资有限公司 owning 29.78% and 大连三鑫投资有限公司 holding 28.26% of shares [6] - The company has a total of 13,401 ordinary shareholders as of the end of the reporting period [6] Research and Development - Research and development expenses were CNY 7,867,543.25, a decrease of 47.2% compared to CNY 14,891,195.96 in the previous year [15] - Research and development expenses decreased to CNY 7,867,543.25 in Q1 2023 from CNY 14,390,713.41 in Q1 2022, a reduction of approximately 45.2% [23] Future Outlook - Future outlook includes potential market expansion and new product development, although specific details were not provided in the financial report [13]